THERAPEUTICSMD INC (TXMD)

US88338N2062 - Common Stock

1.885  +0.01 (+0.27%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

THERAPEUTICSMD INC

NASDAQ:TXMD (5/1/2024, 3:33:45 PM)

1.885

+0.01 (+0.27%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap21.73M
Shares
PEN/A
Fwd PE5.28
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

TXMD Daily chart

Company Profile

TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The firm is focused on developing and commercializing products exclusively for women. The company is engaged in conducting business by out-licensing its products and collecting royalties, after granting a license to commercialize the Company's IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands in the United States and its possessions and territories and assigning the Company’s exclusive license to commercialize ANNOVERA in the United States and its possessions and territories to Mayne Pharma. ANNOVERA is a one-year (13 cycles) ring-shaped contraceptive vaginal system (CVS)). ANNOVERA, which is made with a silicone elastomer, contains segesterone acetate, a 19-nor progesterone derivative also known as Nestorone (SA) and ethinyl estradiol (EE). Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.

Company Info

THERAPEUTICSMD INC

951 Yamato Road, Suite 220

Boca Raton FLORIDA 33431

P: 15619611900

CEO: Robert G. Finizio

Employees: 1

Website: https://www.therapeuticsmd.com/

TXMD News

News Imagea month ago - TherapeuticsMD, Inc.TherapeuticsMD Announces Full Year 2023 Financial Results
News Image6 months ago - Seeking AlphaTherapeuticsMD exploring strategic alternatives for company (NASDAQ:TXMD)

TherapeuticsMD (TXMD) said it is exploring strategic alternatives for the company, including a possible business combination or asset sale. Read more here.

News Image6 months ago - TherapeuticsMD, Inc.TherapeuticsMD Announces Third Quarter 2023 Financial Results
News Image9 months ago - TherapeuticsMD, Inc.TherapeuticsMD Announces Second Quarter 2023 Financial Results
News Imagea year ago - TherapeuticsMD, Inc.TherapeuticsMD Announces First Quarter 2023 Financial Results
News Imagea year ago - TherapeuticsMD, Inc.TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

TXMD Twits

Here you can normally see the latest stock twits on TXMD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example